mAbxience Research - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsmAbxience Research

mAbxience Research

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Alymsys	Bevacizumab	2021-03-26		Renal cell carcinoma , Colorectal neoplasms , Breast neoplasms , Ovarian neoplasms , Non-small-cell lung carcinoma , Glioblastoma , Fallopian tube neoplasms , Kidney neoplasms , Uterine cervical neoplasms , Peritoneal neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

non-small-cell lung carcinoma

,

,

,

type 2 diabetes mellitus

,

diabetes mellitus

,

,

,

,

,

left ventricular hypertrophy

,

,

hyperlipidemias

,

hyperlipoproteinemias

,

,

,

,

kidney diseases

,

chronic renal insufficiency

,

hyperparathyroidism

,

secondary hyperparathyroidism

,

neoplasm metastasis

,

chronic kidney failure

,

,

renal insufficiency

,

diabetic nephropathies

,

vitamin d deficiency

,

cardiovascular diseases

,

,

,

atherosclerosis

,

esophageal neoplasms

,

,

,

metabolic bone diseases

,

,

,

,

,

atrial fibrillation

,

,

,

kidney transplantation

,

stomach neoplasms

,

gastrointestinal stromal tumors

,

,

protein-energy malnutrition

,

rheumatoid arthritis

,

,

hepatocellular carcinoma

,

liver neoplasms

,

,

,

,

kidney neoplasms

,

adenoviridae infections

,

,

hodgkin disease

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

invasive hydatidiform mole

,

hypersensitivity

,

hepatocellular carcinoma

,

,

,

,

mullerian mixed tumor

,

,

urinary bladder neoplasms

,

serous cystadenocarcinoma

,

peritoneal neoplasms

,

,

t-cell lymphoma

,

,

,

primitive neuroectodermal tumors

,

primitive neuroectodermal tumors peripheral

,

neuroectodermal tumors

,

renal cell carcinoma

,

colorectal neoplasms

,

,

,

triple negative breast neoplasms

,

fallopian tube neoplasms

,

non-hodgkin lymphoma

,

endometrial neoplasms

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

,

,

breast neoplasms

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

,

,

hand-foot syndrome

,

drug-related side effects and adverse reactions

,

follicular lymphoma

,

prostatic neoplasms

,

,

colorectal neoplasms

,

breast neoplasms

,

ovarian neoplasms

,

pancreatic neoplasms

,

,

stomach neoplasms

,

head and neck neoplasms

,

thyroid neoplasms

,

esophageal neoplasms

,

,

,

uterine neoplasms

,

,

kidney neoplasms

myelodysplastic syndromes

,

myeloid leukemia acute

,

hematologic neoplasms

,

,

non-hodgkin lymphoma

,

,

,

,

,

colorectal neoplasms

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

lymphoid leukemia

,

esophageal neoplasms

,

Hydroxydaunomycin

,

,

,

kidney neoplasms

,

adenoviridae infections

,

,

hodgkin disease

,

,

,

multiple myeloma

,

plasma cell neoplasms

,

invasive hydatidiform mole

,

hypersensitivity

,

hepatocellular carcinoma

,

,

,

,

mullerian mixed tumor

,

,

urinary bladder neoplasms

,

serous cystadenocarcinoma

,

peritoneal neoplasms

,

,

t-cell lymphoma

,

,

,

primitive neuroectodermal tumors

,

primitive neuroectodermal tumors peripheral

,

neuroectodermal tumors

,

renal cell carcinoma

,

colorectal neoplasms

,

,

,

triple negative breast neoplasms

,

fallopian tube neoplasms

,

non-hodgkin lymphoma

,

endometrial neoplasms

,

large b-cell lymphoma diffuse

,

b-cell lymphoma

,

,

,

breast neoplasms

,

ovarian neoplasms

,

ovarian epithelial carcinoma

,

,

,

hand-foot syndrome

,

drug-related side effects and adverse reactions

,

follicular lymphoma

,

© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use